Huawei Debuts “Driving Mobility and Logistics into the Intelligent World” Vision for Transportation, Powered by Five New Solutions

2 months ago

BARCELONA, Spain, March 9, 2026 /PRNewswire/ -- At MWC Barcelona 2026, Huawei hosted a forum titled Accelerate Transportation Digital Intelligence.…

NYSE Content Update: America250 Chair Rosie Rios Rings Bell to Highlight Partnership

2 months ago

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 9, 2026 /PRNewswire/ -- The New York…

ONLY’s Cultural Blue Movement Featuring Sara Tendulkar, Jonita Gandhi & Mermaid Scales Makes Denim Louder Than Ever

2 months ago

MUMBAI, India, March 9, 2026 /PRNewswire/ -- Blue isn't just a colour, it is a mood, a movement, and a cultural…

AIP Capital Announces Dimuth Fernando as Chief Commercial Officer

2 months ago

STAMFORD, Conn. and SINGAPORE and DUBLIN and NEW YORK, March 9, 2026 /PRNewswire/ -- AIP Capital, an alternative investment manager focused…

LECTRA : Monthly declaration of the total number of shares and voting rights composing the company’s capital (at February 28th,2026)

2 months ago

Monthly declaration of the total number of shares and voting rights composing the company's capital (at February 28th, 2026) This…

Darktrace Appoints Ed Jennings as President and CEO

2 months ago

Veteran Leader Brings Deep Software and Cybersecurity Experience March 09, 2026 13:00 ET  | Source: Darktrace Cambridge, UK, March 09,…

Dstillerys Melinda Han Williams Named to ADWEEKs AI Power 50

2 months ago

Dstillery Chief Data Scientist recognized for AI innovation March 09, 2026 12:52 ET  | Source: Dstillery, Inc. NEW YORK, March…

Surgery Partners, Inc. to Present at Upcoming Investor Conference

2 months ago

March 09, 2026 12:04 ET  | Source: Surgery Partners, Inc. BRENTWOOD, Tenn., March 09, 2026 (GLOBE NEWSWIRE) -- Surgery Partners,…

Zealand Pharma to participate in upcoming investor conferences in March 2026

2 months ago

March 09, 2026 12:01 ET  | Source: Zealand Pharma Press release – No. 5 / 2026 Zealand Pharma to participate…

CORRECTING & REPLACING — MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism

2 months ago

Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3 in Q3 2026 March 09, 2026 10:21 ET…